BIRC2 and plasma cell myeloma: Deletions of NFκB-pathway modulating genes TNFAIP3, BIRC2/BIRC3, TRAF3 or CYLD were identified in 16.6, 4.8, 13.9 and 16.9% of Myeloma XI cases, respectively.